|
|
Volumn 34, Issue 11, 2010, Pages
|
|
Safety and efficacy of bortezomib, melphalan and low doses dexamethasone (VM-dex) in newly diagnosed patients with multiple myeloma
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACICLOVIR;
BORTEZOMIB;
DEXAMETHASONE;
MELPHALAN;
ANTINEOPLASTIC AGENT;
BORONIC ACID DERIVATIVE;
PYRAZINE DERIVATIVE;
AGED;
ANEMIA;
BLOOD TOXICITY;
BONE BIOPSY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CANCER STAGING;
CANCER SURVIVAL;
CHROMOSOME 13Q;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DEEP VEIN THROMBOSIS;
DIABETES MELLITUS;
DIARRHEA;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG SAFETY;
ELDERLY CARE;
FATIGUE;
FEBRILE NEUTROPENIA;
FEMALE;
FLUORESCENCE IN SITU HYBRIDIZATION;
FOLLOW UP;
GENE DELETION;
HERPES ZOSTER;
HUMAN;
IMMUNOHISTOCHEMISTRY;
INFECTION;
LETTER;
LOW DRUG DOSE;
MALE;
MENTAL DISEASE;
MULTIPLE CYCLE TREATMENT;
MULTIPLE MYELOMA;
NEUTROPENIA;
OVERALL SURVIVAL;
PARESTHESIA;
PERIPHERAL NEUROPATHY;
PNEUMONIA;
PRIORITY JOURNAL;
SIDE EFFECT;
SURVIVAL TIME;
THROMBOCYTOPENIA;
TREATMENT DURATION;
VIRUS REACTIVATION;
ADVERSE DRUG REACTION;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BORONIC ACIDS;
DEXAMETHASONE;
DRUG TOXICITY;
FEMALE;
HUMANS;
MALE;
MELPHALAN;
MULTIPLE MYELOMA;
PYRAZINES;
TREATMENT OUTCOME;
DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS;
|
|
EID: 77957019855
PISSN: 01452126
EISSN: None
Source Type: Journal
DOI: 10.1016/j.leukres.2010.05.025 Document Type: Letter |
|
Times cited : (3)
|
|
References (5)
|
